COVID-19

SARS-CoV-2 genome structures and their interactions with human RNA are shown to be important in virus survival and pathogenicity.

A new smartphone app improves the reliability of on-site rapid COVID-19 colorimetric tests, paving the way for safe gatherings in the post-pandemic world.

Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.

Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible to damage from SARS-CoV-2 infections.

Unique immune responses shield some COVID-19 patients from the disease’s worst effects.

A new, cost-effective barrier enclosure protects healthcare workers by effectively containing airborne viral particles from COVID-19 patients.

Elevated levels of inflammatory factors may be linked to persistent COVID-19 symptoms, researchers find.

By knowing the environmental impact of reusable and single-use face masks, policymakers can make data-driven decisions on their use in Singapore.

Tracking how SARS-CoV-2 interacts with host cell receptors during infections may give us new ideas for COVID-19 drug targets.

Some neutralizing antibodies against SARS-CoV-2 may heighten lung tissue damage from COVID-19, an A*STAR study finds.

From forming protective physical barriers to stabilizing mRNA vaccines, polymers provide endless solutions to the threat of coronaviruses and other current and impending diseases.

In COVID-19 long-haulers, an unrelenting immune response damages blood vessels, making them more susceptible to developing blood clots.